TAMPA, Fla., Nov. 7, 2015 /PRNewswire/ – CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory Care (AARC) at the 61st International Respiratory Congress and Exhibition being held today through Nov. 10 in Tampa, Fla.
Voted on by AARC members, the Zenith Award is given to the top corporations in the respiratory care industry and is widely considered the "people's choice" award of the respiratory care profession. Members are asked to evaluate companies that have the most outstanding: Quality of equipment and supplies; Accessibility and helpfulness of sales personnel; Responsiveness; Service record; Truth in advertising; and Support of the respiratory care profession. This marks the eighth time that CareFusion has received this award.
"We have been dedicated to the respiratory care profession since 1955 when Dr. Forrest Bird developed the first mechanical ventilator, and we strive to continue his tradition of innovation, quality, support and service to the respiratory care community," said Ruth Lundstrom, vice president and general manager of Ventilation at CareFusion. "On behalf of more than 100 respiratory care professionals at CareFusion that support our customers and their patients, it is an honor to receive the Zenith award and serve this profession."
CareFusion is highlighting its respiratory solutions in booth 401 at the AARC Congress including ventilators, respiratory diagnostics and AirLife respiratory products.
About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.
For more information on BD, please visit bd.com.
About CareFusion
CareFusion, a BD company, serves the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps and IV sets, MaxPlus® and MaxZero™ IV connectors and sets, Pyxis® automated dispensing and patient identification systems, AVEA®, LTV® series and AirLife® ventilation and respiratory products, ChloraPrep® products, MedMined services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. For more information please visit www.carefusion.com.